Companies › AMGN
AMGEN INC (AMGN)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0000318154 · EDGAR filings · Updated 2026-06-11
AMGEN INC (AMGN) has reported institutional ownership of 79.3%, with 3,104 institutional managers holding positions valued at $150.4B per the latest 13F reporting period.
Latest updates
- 2026-06-11 — 11-K filed
- 2026-06-11 — 11-K filed
- 2026-05-21 — Insider transaction reported (Form 4)
- 2026-05-21 — Insider transaction reported (Form 4)
- 2026-05-21 — Insider transaction reported (Form 4)
- 2026-05-21 — Insider transaction reported (Form 4)
- 2026-05-21 — Insider transaction reported (Form 4)
- 2026-05-21 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, AMGEN INC has 3,104 institutional holders and institutional ownership of 79.3%.
| # | Institution | Reported value | % of tracked total |
|---|---|---|---|
| 1 | BlackRock, Inc. | $16.6B | 11.0% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | $12.3B | 8.2% |
| 3 | STATE STREET CORP | $10.7B | 7.1% |
| 4 | Capital World Investors | $10.3B | 6.9% |
| 5 | MORGAN STANLEY | $5.57B | 3.7% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | $5.41B | 3.6% |
| 7 | VANGUARD PORTFOLIO MANAGEMENT LLC | $5.14B | 3.4% |
| 8 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4.49B | 3.0% |
| 9 | PRIMECAP MANAGEMENT CO/CA/ | $3.12B | 2.1% |
| 10 | JPMORGAN CHASE & CO | $2.54B | 1.7% |
Full holder history and quarter-over-quarter changes are available inside the app.
Insider activity
Insiders reported 103 transactions (0 buys, 10 sells) across 22 reporting insiders, with a net reported value of −$25.9M.
Quarterly net insider value, as reported in Form 4 filings.
Debt maturity schedule
Principal coming due by year for AMGEN INC, from the company's own SEC prospectus filings (424B) tracked by Sightfile.
| Year | Bond series maturing | Known principal due |
|---|---|---|
| 2026 | 1 | $1.25B |
| 2027 | 2 | $2.00B |
| 2028 | 2 | $5.00B |
| 2029 | 3 | $2.00B |
| 2030 | 2 | $3.25B |
| 2031 | 2 | $2.25B |
| 2032 | 2 | $2.25B |
| 2033 | 3 | — |
| 2036 | 1 | — |
| 2037 | 2 | — |
| 2038 | 1 | — |
| 2039 | 1 | — |
Coupons, seniority and prospectus links for each series are available inside the app.
Fails-to-deliver
The SEC's fails-to-deliver file for 2026-06-26 reports 2,611 failed-to-deliver shares ($921.2K) for AMGN — an official data point published by the SEC, shown as reported.
Related companies
JOHNSON & JOHNSON (JNJ) · ABBVIE INC (ABBV) · MERCK & CO. INC. (MRK) · ASTRAZENECA PLC (AZN) · GILEAD SCIENCES INC (GILD) · ABBOTT LABS (ABT)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-11.